{"DataElement":{"publicId":"2787415","version":"1","preferredName":"Anti-Thymocyte Globulin Or Antilymphocyte Serum Source Specify Text","preferredDefinition":"The free-text field to describe the source for anti-thymocyte globulin or antilymphocyte serum.","longName":"2787412v1.0:2799057v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2787412","version":"1","preferredName":"Anti-Thymocyte Globulin Or Antilymphocyte Serum Source","preferredDefinition":"A purified gamma immunoglobulin (IgG) with immunosuppressive activity. Obtained from animals that have been immunized with human thymocytes, antithymocyte globulin (ATG) specifically recognizes and destroys T lymphocytes. Although not completely understood, the mechanism of action appears to involve T lymphocyte clearance from the circulation and modulation of T lymphocyte activity. Administering ATG with chemotherapy prior to stem cell transplantation may reduce the risk of graft-versus-host (GVH) disease._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Immunoglobulins raised xenogeneically against lymphocyte populations.  It is used both as a test for histocompatibility and in conjunction with other immunosuppressive agents to suppress rejection of grafts or organ transplants._Where something is available or from where it originates.","longName":"ATG_OR_ALS_SRC","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2861802","version":"1","preferredName":"Antithymocyte Globulin Or Antilymphocyte Serum","preferredDefinition":"A purified gamma immunoglobulin with immunosuppressive properties.  Obtained from rabbits that have been immunized with human thymocytes, antithymocyte globulin specifically recognizes and destroys T lymphocytes.  Although the exact mechanism of action is not completely understood, it appears to involve T lymphocyte clearance from the circulation and modulation of T lymphocyte activity. Administering antithymocyte globulin with chemotherapy prior to stem cell transplantation may reduce the risk of graft-versus-host disease. (NCI04):Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Immunoglobulins raised xenogeneically against lymphocyte populations.  It is used both as a test for histocompatibility and in conjunction with other immunosuppressive agents to suppress rejection of grafts or organ transplants.","longName":"C278:C37998:C62577","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-Thymocyte Globulin","conceptCode":"C278","definition":"Purified gamma globulin, with immunosuppressive activity. Obtained from animals that have been immunized with human thymocytes, antithymocyte globulin (ATG) specifically recognizes and destroys T lymphocytes. Although not completely understood, the mechanism of action appears to involve T lymphocyte clearance from the circulation and modulation of T lymphocyte activity. Administering ATG with chemotherapy prior to stem cell transplantation may reduce the risk of graft-versus-host (GVH) disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Antilymphocyte Serum","conceptCode":"C62577","definition":"Immunoglobulins raised xenogeneically against lymphocyte populations.  It is used both as a test for histocompatibility and in conjunction with other immunosuppressive agents to suppress rejection of grafts or organ transplants.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6811B47C-6B53-8BA0-E040-BB89AD4309AA","latestVersionIndicator":"Yes","beginDate":"2009-04-21","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-04-21","modifiedBy":"ONEDATA","dateModified":"2009-04-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2223297","version":"1","preferredName":"Source","preferredDefinition":"Where something is available.","longName":"C25683","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Source","conceptCode":"C25683","definition":"Where something is available or from where it originates.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62B04C0-71B2-23A7-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57A6D22E-9602-6172-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-04-28","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-09-24","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2799057","version":"1","preferredName":"Specify Text","preferredDefinition":"Be specific about something; define clearly._Text; the words of something written.","longName":"SPC_TXT","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2799056","version":"1","preferredName":"Specify Text","preferredDefinition":"Specify; be specific about something; define clearly.:Text; the words of something written.","longName":"C25685:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FE321-D89B-66BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-11","modifiedBy":"ONEDATA","dateModified":"2008-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FE321-D8AC-66BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-11","modifiedBy":"MALUMK","dateModified":"2021-01-19","changeDescription":"03/17/10-Added CSI for F2000-CJL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964902","version":"1","longName":"2100r1: 100 Days Post-HSCT Data","context":"NHLBI"},{"publicId":"2964922","version":"1","longName":"2200r1: 6 Month to 2 Year Post-HSCT Data","context":"NHLBI"},{"publicId":"2964923","version":"1","longName":"2300r1: Greater Than 2 Years Post-HSCT Data","context":"NHLBI"}]},{"publicId":"2842912","version":"1","longName":"Therapy","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2842918","version":"1","longName":"Administration","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"cgvhd_trt_atg_src_othr","type":"NMDP_FN","context":"NHLBI"},{"name":"agvhd_prevent_atg_othr","type":"NMDP_FN","context":"NHLBI"},{"name":"agvhd_trt_atg_othr_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"Animal:speciesCode","type":"HCT_BRIDG","context":"NHLBI"},{"name":"base_pre_HCT_prep_med_animal_source_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_gvhd_prophy_med_animal_source_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_pre_hct_prep_med_animal_source_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_med_animal_source_sp","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_p_med_anim_source_sp","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_med_animal_source_sp","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_med_animal_srce_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_med_animal_source_spec","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify the ALS, ALG, ATS, AT","type":"Preferred Question Text","description":"Specify the ALS, ALG, ATS, ATG animal source:","url":null,"context":"NHLBI"},{"name":"Specify:","type":"Alternate Question Text","description":"Specify:","url":null,"context":"NHLBI"},{"name":"Specify source","type":"Alternate Question Text","description":"Specify source","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2787415","type":"BRIDG Mapping Path","description":"\"PerformedProcedure > SubstanceExtractionAdministrationRelationship > PerformedSubstanceExtraction > Subject [donor] > Animal.speciesCode(CD).originalText WHERE PerformedProcedure > DefinedProcedure.reasonCode = \"\"prevent GVHD\"\" AND DefinedProcedure > DefinedCompositeRelationship > DefiendActivity AND DefinedActivity.nameCode = \"\"Perform composite preparative regimen\"\"\"","url":null,"context":"NHLBI"},{"name":"Specify other source:","type":"Application Standard Question Text","description":"Specify other source:","url":null,"context":"NHLBI"},{"name":"Specify other source:","type":"Alternate Question Text","description":"Specify other source:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57A8277C-13E9-7138-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-24","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-09-24","modifiedBy":"KUMMEROA","dateModified":"2021-08-18","changeDescription":".Added AQT for 2000. AK 9/6/13 Added alt name for 2000. AK 10/2/13 Added alt name for 2400. AK 10/15/13. Added human readable def. System generated def displayed as alt def. No version needed. AK 10/7/14. 2/25/16mn-removed 'animal' from def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}